Abstract
Background This systematic review aims to evaluate central nervous system involvement in context of miliary pulmonary tuberculosis.
Methods We included studies on central nervous system infections associated with miliary pulmonary tuberculosis involving human subjects in any language. Patients with disseminated tuberculosis involving two non-contiguous organs were excluded. Databases searched included PubMed, Scopus, Embase, and Google Scholar. Case reports, case series, and observational studies with confirmed diagnoses were included. The review follows PRISMA guidelines and is registered with PROSPERO (CRD42024542130).
Results The review included 158 records describing 161 patients. The mean age was 32.7 years, with 53.4% females. Key comorbid conditions included human immunodeficiency virus positivity (6.8%), immunosuppressive therapy (9.9%), and chronic kidney disease (2.5%). Common clinical features were fever (58.4%), headache or vomiting (41.6%), and altered sensorium (26.7%). Frequent neuroimaging abnormalities were miliary or multiple brain tuberculomas (66.5%), basal exudates (7.5%), vertebral tuberculosis (7.5%), cerebral infarcts (6.8%), and spinal cord tuberculoma or abscess (6.2%). Paradoxical manifestations occurred in one-third of cases, including new or enlarged brain lesions (22.4%) and paradoxical cerebral infarcts (2.5%). Cerebrospinal fluid findings were normal or unavailable in 45.3% of cases. Positive diagnostic tests included smear, culture, polymerase chain reaction, or GeneXpert in 25% of cases, with 5% showing drug resistance. Improvement was seen in 80.8% of patients, while 9.9% either died or did not improve.
Conclusion This review highlights diverse central nervous system involvement in miliary pulmonary tuberculosis, including tuberculous meningitis and spinal cord lesions, with common paradoxical manifestations and significant patient improvement with following treatment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
There are no major revisions.
Data Availability
All data lies in the manuscript or supplementary items.
